Work

Supplementary Data from Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma

Year: 2023

Type: supplementary-materials

Abstract: Supplementary figures

DOI: 10.1158/1078-0432.22474355.v1

Authors: Asfar S. Azmi, Husain Yar Khan, Irfana Muqbil, Amro Aboukameel, Jasper E. Neggers, Dirk Daelemans, Amit Mahipal, Gregory Dyson, Mandana Kamgar, Mohammad Najeeb Al-Hallak, Anteneh Tesfaye, Steve Kim, Vinod Shidham, Ramzi M. Mohammad, Philip A. Philip

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361962348

Cites:

Cited by:

Related to: 10